Setting higher expectations in healing & recovery
Pioneering cellular & tissue‑based innovations
Organogenesis is a leading regenerative medicine company focused on improving lives.
NASDAQ CN: ORGO
-0.0495 (-2.75%)
Latest news
Sign up for
email alerts
Never miss an update. Get Organogenesis investor alerts for quotes, filings, events, and news straight to your inbox.